Oral simvastatin administration delays castration-resistant progression and reduces intratumoral steroidogenesis of LNCaP prostate cancer xenografts

Oral simvastatin administration delays castration-resistant progression and reduces intratumoral steroidogenesis of LNCaP prostate cancer xenografts Prostate Cancer and Prostatic Diseases advance online publication, August 4 2015. doi:10.1038/pcan.2015.37 Authors: J A Gordon, A Midha, A Szeitz, M Ghaffari, H H Adomat, Y Guo, T L Klassen, E S Guns, K M Wasan & M E Cox
Source: Prostate Cancer and Prostatic Diseases - Category: Urology & Nephrology Authors: Source Type: research